Found: 2
Select item for more details and to access through your institution.
Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 5, p. 1217, doi. 10.1007/s00277-019-03639-5
- By:
- Publication type:
- Article
Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia.
- Published in:
- 2019
- By:
- Publication type:
- journal article